Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/30/2010US20100330082 Nlrr-1 antagonists and uses thereof
12/30/2010US20100330077 1-acetic acid-indole derivatives with pgd2 antagonist activity
12/30/2010US20100330069 Heterocyclic compounds and methods of use
12/30/2010US20100330067 Compounds and Methods for the Modulation of Toll-Like Receptor Function
12/30/2010US20100330064 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them
12/30/2010US20100330063 Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells
12/30/2010US20100330061 Methods and Devices for Treating Lung Dysfunction
12/30/2010US20100330039 Schizochytrium Fatty Acid Synthase (FAS) and Products and Methods Related Thereto
12/30/2010US20100330038 Methods for expressing proteins in axons
12/30/2010US20100330037 Adenoviral systems and the uses thereof
12/30/2010US20100330035 Pharmaceutical Compositions for Treatment of HCV Patients that are Poor-Responders to Interferon
12/30/2010US20100330032 Heterocyclic antiviral compounds
12/30/2010US20100330030 Vasculostatic Agents and Methods of Use Thereof
12/30/2010US20100330026 Organic polymeric photon up-conversion nanoparticles for biological applications
12/30/2010US20100330023 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same
12/30/2010US20100330022 Refreshing cream foundation in gel form
12/30/2010US20100330021 Substituted (thiazol-2-yl)-amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
12/30/2010US20100330017 Enhanced shine and moisture lip composition
12/30/2010US20100330014 Composition for external application on skin, and skin-whitening cosmetic
12/30/2010US20100330011 Silicone-Organic Gels with Polyalkyloxylene Crosslinked Silicone Elastomers
12/30/2010US20100330009 Coumestan-like antioxidants and uv absorbants
12/30/2010US20100330006 Antimicrobial lotion compositions
12/30/2010US20100330001 Antibacterial compositions
12/30/2010US20100329998 Novel heterocycles
12/30/2010US20100329997 Use of creatine or creatine compounds for skin preservation
12/30/2010US20100329996 Novel Combination of Therapeutic Agents
12/30/2010US20100329993 Method of fixing and expressing physiologically active substance
12/30/2010US20100329992 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
12/30/2010US20100329982 Particles with inducible change of shape
12/30/2010US20100329978 Highly selective sigma receptor ligands
12/30/2010US20100329976 Nanoparticulate compositions of angiogenesis inhibitors
12/30/2010US20100326437 Inhalable medicament
12/30/2010DE102009030199A1 Applikator zum Abgeben eines Produktes auf Haar An applicator for dispensing a product to hair
12/30/2010DE102009029717A1 Medical product, useful for post-surgical adhesion prophylaxis and/or hemostasis, comprises physically crosslinked polyvinyl alcohol and at least one biocompatible nucleating agent
12/30/2010DE10029047B4 Verwendung von Luteolin-7-O-glucuronid als Wirkstoff in einem anticholestatischen Arzneimittel The use of luteolin 7-O-glucuronide as the active ingredient in a pharmaceutical anticholestatischen
12/30/2010CA2671029A1 Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
12/29/2010WO2010151896A1 Solid drug tablets for implantable drug delivery devices
12/29/2010WO2010151893A1 Implantable drug delivery devices and methods of making the same
12/29/2010WO2010151852A2 Protease inhibitors, compositions and methods of use
12/29/2010WO2010151827A1 X-box binding proteins (xbp-1) variants and methods of using the same
12/29/2010WO2010151815A2 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
12/29/2010WO2010151799A2 Compounds for modulating rna binding proteins and uses therefor
12/29/2010WO2010151797A2 Compounds for modulating rna binding proteins and uses therefor
12/29/2010WO2010151791A1 Heterocyclic compounds and their uses
12/29/2010WO2010151784A2 Antimicrobial compounds
12/29/2010WO2010151778A2 Topical compositions and methods for wound care
12/29/2010WO2010151741A1 Abuse resistant oral dosage forms
12/29/2010WO2010151735A2 Heterocyclic compounds and their uses
12/29/2010WO2010151731A1 Materials and methods for the identification of drug-resistant cancers and treatment of same
12/29/2010WO2010151710A2 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
12/29/2010WO2010151697A1 Method for treating a patient in need of aspirin therapy
12/29/2010WO2010151689A1 Heterocyclic compounds for the treatment of neurological and psychological disorders
12/29/2010WO2010151674A2 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
12/29/2010WO2010151638A1 Jnk inhibitors for use in treating spinal muscular atrophy
12/29/2010WO2010151611A1 Novel fumarate salts of a histamine h3 receptor antagonist
12/29/2010WO2010151597A1 Methods for using pyrrolo-benzo-1,4-diazines as sodium channel blockers
12/29/2010WO2010151595A1 Pyrrolo-benzo-1,4-diazines useful as sodium channel blockers
12/29/2010WO2010151577A1 Compounds and methods for treating influenza
12/29/2010WO2010151565A2 Combination therapies for the treatment of obesity
12/29/2010WO2010151551A1 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS
12/29/2010WO2010151541A1 Polymorphic form d of bazedoxifene acetate and methods of preparing same
12/29/2010WO2010151530A1 Method for treatment of diseases
12/29/2010WO2010151503A2 Combination therapies for the treatment of obesity
12/29/2010WO2010151488A1 Combination of boceprevir with 5- ( { 6- [2, 4- bis (trifluoromethyl) phenyl] pyridazin-3 -yl } methyl) -2- (2 -fluorophenyl) -5h- imidazo [4, 5-c] pyridine for the treatment of hcv
12/29/2010WO2010151487A1 Combination of telaprevir with 5- ({6- [2,4-bis (trifluoromethyl) phenyl] pyridazin-3 -yl)methyl) -2- (2 -fluorophenyl) -5h- imidazo [4, 5-c]pyridine for the treatment of hcv
12/29/2010WO2010151472A1 Combination of a ns5b polymerase inhibitor and a hcv ns3 protease inhibitor for the treatment of hcv
12/29/2010WO2010151441A1 Benzamide derivatives
12/29/2010WO2010151439A1 Cross-linked polyallylamine tablet core
12/29/2010WO2010151338A2 Myostatin inhibitor enhancement of musculoskeletal repair
12/29/2010WO2010151318A1 Substituted hydroxamic acids and uses thereof
12/29/2010WO2010151317A1 Substituted hydroxamic acids and uses thereof
12/29/2010WO2010151314A1 Diffusion enhancing compounds and their use alone or with thrombolytics
12/29/2010WO2010151281A1 Methods and kits for treating joints and soft tissues
12/29/2010WO2010151241A1 Topical composition containing naproxen
12/29/2010WO2010151240A1 Topical composition containing ibuprofen
12/29/2010WO2010151216A1 Method for treating a patient at risk for developing an nsaid-associated ulcer
12/29/2010WO2010151173A1 Nano-dispersed composition containing coenzyme q10 and method for producing same
12/29/2010WO2010151160A1 O-substituted 3-n-heteroaryl-1,3,4-oxadiazolones for medical use
12/29/2010WO2010151096A1 Therapeutic combinations of nicotinic acid and meldonium
12/29/2010WO2010151095A1 Novel acetylsalicylic acid salts
12/29/2010WO2010151080A2 Pharmaceutical composition containing carboxylosartan and a production method therefor
12/29/2010WO2010151074A2 Photosensitizer containing conjugates of quantum dot-chlorine derivatives and composition for treating and diagnosing cancer containing same for photodynamic therapy
12/29/2010WO2010151073A2 Conjugates of anticancer chemotherapeutic agent-chlorine derivatives, photosensitizer containing same and composition for treating cancer containing same
12/29/2010WO2010151020A2 Fast-dissolving oral film for effectively concealing unpleasant tastes
12/29/2010WO2010151005A2 Injectable composition containing hydroxychloroquine for local administration for treating cancer
12/29/2010WO2010151004A2 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids
12/29/2010WO2010150995A2 Compositions for treating drug addiction and improving addiction-related behavior
12/29/2010WO2010150984A2 Amorphous adefovir dipivoxil solid dispersion with improved stability, and method for preparing same
12/29/2010WO2010150944A1 Composition for the management and improvement of oral health
12/29/2010WO2010150930A1 Fast dissolving film for oral administration which prevents unpleasant taste effectively
12/29/2010WO2010150927A1 Pharmaceutical composition for prevention and treatment of cancer diseases comprising benzamide derivatives
12/29/2010WO2010150921A1 Therapeutic agent for hypertension or normal high blood pressure
12/29/2010WO2010150899A1 Novel thiophene carboxamide derivative and medicinal use of same
12/29/2010WO2010150867A1 Fermentation product of a cereal-derived material and immunomodulator
12/29/2010WO2010150865A1 Crystals
12/29/2010WO2010150840A1 N-substituted-cyclic amino derivative
12/29/2010WO2010150837A1 Indoline derivative
12/29/2010WO2010150836A1 Enhancer of activity of nucleic acid analogue
12/29/2010WO2010150819A1 Therapeutic agent for ischemic cerebrovascular disorders
12/29/2010WO2010150812A1 Ophthalmic composition and method for prevention of cloudiness/precipitation
1 ... 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 ... 7860